North America Antibiotics Market Size

North America Antibiotics Market Size, Share & Analysis by 2026

North America Antibiotics Market By Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors), By Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, and Others), By Country, Industry Analysis and Forecast, 2020 - 2026

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Published Date : February-2021 | Number of Pages : 88 | Format : PDF

TABLE 1 North America Antibiotics Market, 2016 - 2019, USD Million
TABLE 2 North America Antibiotics Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Antibiotics Market
TABLE 4 Product Launches And Product Expansions– Antibiotics Market
TABLE 5 Approvals– Antibiotics Market
TABLE 6 Acquisition and Mergers– Antibiotics Market
TABLE 7 North America Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 8 North America Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 9 North America Cell Wall Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 10 North America Cell Wall Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 11 North America Protein Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 12 North America Protein Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 13 North America DNA Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 14 North America DNA Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 15 North America RNA Synthesis Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 16 North America RNA Synthesis Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 17 North America Mycolic Acid Inhibitors Market by Country, 2016 - 2019, USD Million
TABLE 18 North America Mycolic Acid Inhibitors Market by Country, 2020 - 2026, USD Million
TABLE 19 North America Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 20 North America Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 21 North America Cephalosporin Market by Country, 2016 - 2019, USD Million
TABLE 22 North America Cephalosporin Market by Country, 2020 - 2026, USD Million
TABLE 23 North America Penicillin Market by Country, 2016 - 2019, USD Million
TABLE 24 North America Penicillin Market by Country, 2020 - 2026, USD Million
TABLE 25 North America Fluoroquinolone Market by Country, 2016 - 2019, USD Million
TABLE 26 North America Fluoroquinolone Market by Country, 2020 - 2026, USD Million
TABLE 27 North America Macrolides Market by Country, 2016 - 2019, USD Million
TABLE 28 North America Macrolides Market by Country, 2020 - 2026, USD Million
TABLE 29 North America Carbapenem Market by Country, 2016 - 2019, USD Million
TABLE 30 North America Carbapenem Market by Country, 2020 - 2026, USD Million
TABLE 31 North America Aminoglycosides Market by Country, 2016 - 2019, USD Million
TABLE 32 North America Aminoglycosides Market by Country, 2020 - 2026, USD Million
TABLE 33 North America Sulfonamides Market by Country, 2016 - 2019, USD Million
TABLE 34 North America Sulfonamides Market by Country, 2020 - 2026, USD Million
TABLE 35 North America Others Market by Country, 2016 - 2019, USD Million
TABLE 36 North America Others Market by Country, 2020 - 2026, USD Million
TABLE 37 North America Antibiotics Market by Country, 2016 - 2019, USD Million
TABLE 38 North America Antibiotics Market by Country, 2020 - 2026, USD Million
TABLE 39 US Antibiotics Market, 2016 - 2019, USD Million
TABLE 40 US Antibiotics Market, 2020 - 2026, USD Million
TABLE 41 US Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 42 US Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 43 US Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 44 US Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 45 Canada Antibiotics Market, 2016 - 2019, USD Million
TABLE 46 Canada Antibiotics Market, 2020 - 2026, USD Million
TABLE 47 Canada Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 48 Canada Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 49 Canada Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 50 Canada Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 51 Mexico Antibiotics Market, 2016 - 2019, USD Million
TABLE 52 Mexico Antibiotics Market, 2020 - 2026, USD Million
TABLE 53 Mexico Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 54 Mexico Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 55 Mexico Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 56 Mexico Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 57 Rest of North America Antibiotics Market, 2016 - 2019, USD Million
TABLE 58 Rest of North America Antibiotics Market, 2020 - 2026, USD Million
TABLE 59 Rest of North America Antibiotics Market by Action Mechanism, 2016 - 2019, USD Million
TABLE 60 Rest of North America Antibiotics Market by Action Mechanism, 2020 - 2026, USD Million
TABLE 61 Rest of North America Antibiotics Market by Drug Class, 2016 - 2019, USD Million
TABLE 62 Rest of North America Antibiotics Market by Drug Class, 2020 - 2026, USD Million
TABLE 63 Key Information – GlaxoSmithKline PLC (GSK)
TABLE 64 Key information –Johnson and Johnson
TABLE 65 key information - Merck & Co., Inc.
TABLE 66 Key Information – Pfizer, Inc.
TABLE 67 Key Information – Bayer AG
TABLE 68 Key Information – Novartis AG
TABLE 69 Key Information – Sanofi S.A.
TABLE 70 Key Information – Abbott Laboratories
TABLE 71 key information – F. Hoffmann-La Roche Ltd.
TABLE 72 Key Information – Eli Lilly and Company

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Jul) Leading Players
FIG 5 Recent strategies and developments: Merck & Co., Inc.
FIG 6 Recent strategies and developments: Pfizer, Inc.
FIG 7 Recent strategies and developments: Sanofi S.A.

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities